Skip to main content
. 2021 Apr 8;10(3):1479–1484. doi: 10.4103/jfmpc.jfmpc_2015_20

Table 2.

Seroprevalence of SARS-CoV-2 antibodies by gender and age groups

Variable Samples collected Crude prevalence In percent Weighted prevalence (95% CI)
Gender
 Male 3680 7.90 7.91% (7.06-8.76)
 Female 3423 7.50 7.57% (6.70-8.44)
Age group
 <18 years 2435 177 7.26% (6.24-8.28)
 18 yrs and above 4668 7.95 7.97% (7.21-8.74)
 18-45 3098 7.13 7.11% (6.22-8.01)
 45-60 1106 10.03 10.04% (8.28-11.80)
 >60 464 8.41 8.40% (5.87-10.92)